Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

Gain Therapeutics, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 4 Alder Matthias (CEO) has filed a Form 4 on Gain Therapeutics, Inc.
Txns: Exercised 825 restricted stock units @ $0
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/10/2023 8-K Quarterly results
Docs: "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS"
07/05/2023 4 Alder Matthias (CEO) has filed a Form 4 on Gain Therapeutics, Inc.
Txns: Exercised 3,300 restricted stock units @ $0
05/12/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/12/2023 8-K Quarterly results
Docs: "Gain Therapeutics, Inc. Press Release"
04/28/2023 ARS Form ARS - Annual Report to Security Holders:
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/23/2023 8-K Quarterly results
12/21/2022 3 Fuggetta Gianluca (Principal Accounting Officer) has filed a Form 3 on Gain Therapeutics, Inc.
12/16/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
09/22/2022 4 RICHMAN ERIC I (Director) has filed a Form 4 on Gain Therapeutics, Inc.
Txns: Granted 329,400 options to buy @ $3.5, valued at $1.2M
Granted 54,900 restricted stock units @ $0
09/22/2022 4 Islam Khalid (Director) has filed a Form 4 on Gain Therapeutics, Inc.
Txns: Granted 10,500 options to buy @ $3.5, valued at $36.8k
09/22/2022 4 Riley Jeffrey Scott (Director) has filed a Form 4 on Gain Therapeutics, Inc.
Txns: Granted 10,500 options to buy @ $3.5, valued at $36.8k
09/22/2022 4 GOLDSTEIN DOV A MD (Director) has filed a Form 4 on Gain Therapeutics, Inc.
Txns: Granted 10,500 options to buy @ $3.5, valued at $36.8k
09/22/2022 4 Melincoff Gwen A (Director) has filed a Form 4 on Gain Therapeutics, Inc.
Txns: Granted 10,500 options to buy @ $3.5, valued at $36.8k
09/22/2022 4 Nicaise Claude (Director) has filed a Form 4 on Gain Therapeutics, Inc.
Txns: Granted 10,500 options to buy @ $3.5, valued at $36.8k
09/22/2022 4 HASLER HANS PETER (Director) has filed a Form 4 on Gain Therapeutics, Inc.
Txns: Granted 10,500 options to buy @ $3.5, valued at $36.8k
09/22/2022 4 Alder Matthias (COO) has filed a Form 4 on Gain Therapeutics, Inc.
Txns: Granted 60,900 options to buy @ $3.5, valued at $213.2k
Granted 10,200 restricted stock units @ $0
09/20/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Transition Agreement, by and between the Company and Eric Richman",
"AMENDED AND RESTATED EMPLOYMENT AGREEMENT This Amended and Restated Employment Agreement is effective as of , by and between Gain Therapeutics, Inc. and Matthias Alder . This Agreement amends, restates, and supersedes in its entirety the Employment Agreement between the Company and Executive entered into effective October 15, 2021 . WHEREAS, the Company desires to continue to retain the services of Executive, now in the role of Chief Executive Officer as further set forth in this Agreement; WHEREAS, the Company’s Board of Directors desires to appoint Executive as the Company’s President and Chief Executive Officer as further set forth in this Agreement, effective as of the Effective Date; and WHEREAS, Executive desires to serve the Company in such capacity, subject to the terms and conditi...",
"GAIN THERAPEUTICS Announces PROMOTION OF Matthias Alder TO chief executive officer"
08/08/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/08/2022 8-K Quarterly results
07/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/15/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
06/17/2022 8-K Quarterly results
06/02/2022 EFFECT Form EFFECT - Notice of Effectiveness:
05/27/2022 4 RICHMAN ERIC I (CEO) has filed a Form 4 on Gain Therapeutics, Inc.
Txns: Bought 2,482 shares @ $2.58, valued at $6.4k
05/23/2022 4 RICHMAN ERIC I (CEO) has filed a Form 4 on Gain Therapeutics, Inc.
Txns: Bought 4,000 shares @ $2.71, valued at $10.8k
Bought 9,256 shares @ $2.83, valued at $26.2k
05/23/2022 S-3/A Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
05/23/2022 4/A Calabrese Salvatore (CFO) has filed a Form 4 on Gain Therapeutics, Inc.
Txns: Bought 3,000 shares @ $2.7, valued at $8.1k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy